From: Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort
Variable
SIR
99% CI
Age
< 60 years
1.14
[0.94-1.38]
≥ 60 years
[1.06-1.23]
T2D duration at study entry
< 1 year
1.27
[1.08-1.47]
1 - 3 years
1.13
[0.94-1.34]
> 3 years
1.10
[1.00-1.21]